Q1 2021

Filed May 21, 2021 · 10-Q · 51 days after period end · 0001654954-21-006101

Q1 2021 · 10-Q

Revenue

$0.00

— vs Q1 2020

Net Income

-$603.00K

N/M vs Q1 2020

EPS Diluted

-$0.04

N/M vs Q1 2020

Gross Profit$0—

Operating Income

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	$0.00	$0.00	$18.00K	$4.00K
Net Income	-$603.00K	$2.73M	-$215.00K	$1.08M
EPS Diluted	-$0.04	$0.04	-$0.07	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR